Sulodexide: it is time for a program against chronic venous disease

Int Angiol. 2014 Jun;33(3):209-11.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Chronic Disease
  • Glycosaminoglycans / adverse effects
  • Glycosaminoglycans / therapeutic use*
  • Humans
  • Treatment Outcome
  • Varicose Veins / diagnosis
  • Varicose Veins / drug therapy*
  • Varicose Veins / epidemiology
  • Venous Insufficiency / diagnosis
  • Venous Insufficiency / drug therapy*
  • Venous Insufficiency / epidemiology

Substances

  • Cardiovascular Agents
  • Glycosaminoglycans
  • glucuronyl glucosamine glycan sulfate